Epizyme CEO Robert Bazemore's 2018 pay rises 2% to $3.7M
Epizyme reports 2018 executive compensation
By ExecPay News
Published: April 18, 2019
Epizyme reported fiscal year 2018 executive compensation information on April 18, 2019.
In 2018, five Epizyme executives received on average a compensation package of $2M, a 3% decrease compared to previous year.
Average pay of disclosed executives at Epizyme
Robert B. Bazemore Jr, Chief Executive Officer, received $3.7M in total, which increased by 2% compared to 2017. 75% of Bazemore's compensation, or $2.7M, was in option awards. Bazemore also received $321K in non-equity incentive plan, $576K in salary, as well as $5.7K in other compensation.
Shefali Agarwal, Chief Medical Officer, received a compensation package of $2M. 74% of the compensation package, or $1.5M, was in option awards.
Matthew Ros, Chief Strategy and Business Officer, earned $1.7M in 2018, a 18% increase compared to previous year.
Susan E. Graf, Former Chief Business Officer, received $1.6M in 2018, which increases by 13% compared to 2017.
Suzanne Fleming, Former Senior Vice President, Finance and Treasurer, earned $763K in 2018.
Related executives
Robert Bazemore
Epizyme
Chief Executive Officer
Susan Graf
Epizyme
Former Chief Business Officer
Suzanne Fleming
Epizyme
Former Senior Vice President, Finance and Treasurer
Matthew Ros
Epizyme
Executive Vice President, Chief Strategy and Business Officer
Shefali Agarwal
Epizyme
Executive Vice President, Chief Medical and Development Officer
You may also like
Source: SEC filing on April 18, 2019.